Arterial and biliary complications after transarterial chemoembolization for hepatocellular carcinoma

doi:10.5306/wjco.v17.i1.113618

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (94)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=58

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=30

Jan 24, 2026 (publication date) through Jan 28, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Jan 24, 2026; 17(1): 113618
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113618

Open in New Tab Full Size Figure Download Figure

Figure 1 Schematic diagram illustrating the classification, pathogenesis, risk factors, and management strategies of arterial and biliary complications associated with different transarterial chemoembolization modalities. TACE: Transarterial chemoembolization; DEB-TACE: Drug-eluting bead transarterial chemoembolization; B-TACE: Balloon-occluded transarterial chemoembolization.

Citation: Wan YX, Lin ZY, Chen LT, Wu RQ, Zhang Y, Du ZQ. Arterial and biliary complications after transarterial chemoembolization for hepatocellular carcinoma. World J Clin Oncol 2026; 17(1): 113618
URL: https://www.wjgnet.com/2218-4333/full/v17/i1/113618.htm
DOI: https://dx.doi.org/10.5306/wjco.v17.i1.113618